Professional Documents
Culture Documents
1. VASCULAR EVENTS:
--- Endothelial cells are most oUen s2mulated by cytokines produced by mast cells, etc.
--- VasoconstricLon of the injured vessel
--- VasodilaLon of the microvessels (especially venues)
· Mediated by histamine, bradykinin:
--- Vasodila2on in the micro vessels ---
Vasoconstric2on in the large vessels
· Venule dilaLon is necessary for decreasing the blood flow to favour the interac2on
between the blood & the endothelial cells
--- Signs = Rubor (redness) & Calor (heat) due to decreased blood flow
--- It will produce stasis (speed of blood flow is decreased)
--- Increased vascular permeability:
· RetracLon/contrac2on of the endothelial cells, which produces larger gaps
between them
· These gaps contain kinin components, cloXng components & cytokines & it will
allow cells to pass through
· Leads to exudate formaLon (due to extravasa2on of fluid)
· Signs = Tumor (swelling)
--- General effects of vasodila0on:
· It is important for ini2a2ng & developing the inflammatory response because they
prepare the area of injury for the cellular effects that follow
· Favours the interacLon of the cells with the injured cells then with the 2ssular cells
at the site of injury
· Favours the interconnecLon of the plasma protein systems & the inflammatory
cells at the site of injury
· Also favours the interconnec2on of the cells of the adap2ve immunity
· Prepares the site for healing mechanisms
2. ACTIVATION OFPLASMAPROTEIN SYSTEMS:
--- COMPLEMENTSYSTEM:
· Classical pathway = ac2vated by immune complexes (Ag---Ab) formed on the surface
of foreign membranes
· LecLn pathway = ac2vated directly by bacterial carbohydrates
· AlternaLve pathway = ac2vated in the presence of bacteria & fungi
· MACs = destroys the foreign membrane
· Opsonins (C3b, IgG) = recognised by C3b receptors on membranes of macrophages
· Anaphylatoxins (C3a, C5a, C4a) = s2mulates inflammatory cells (mast cells)
· The first component of the complement system is C1
--- It can be ac2vated by = plasmin, Factor XIIa, kinin
--- CLOTTINGSYSTEM:
· Factor XIIa = ac2vates C1, plasminogen, coagulaLon cascade
· Fibrinogen = forms fibrin filaments & fibrinopepLdes A & B (are chemotac2c for
neutrophils)
· Fibrin = forms the fibrinoleukocyLc barrier & acts as a skeleton for the repair
process (migra2on of fibroblasts & endothelial cells to form new vessels)
--- KININSYSTEM:
· The final product is bradykinin
· Starts with the acLvaLon of prekallikrein into kallikrein (via Factor XIIa + plasmin)
· Kallikrein ac2vates LMW kininogen into bradykinin
--- Kallikrein can also ac2vate plasminogen
· Bradykinin:
--- Produces endothelial cell retracLon = increases vascular permeability
--- VasodilaLon at low doses
--- Favours leukocyte chemotaxis
--- ContracLon of smooth muscles
-- Pain
3. CELLULAREVENTS:
--- Cells involved in acute inflamma0on:
· Primary = monocytes & (PMNs) & granulocytes
· Secondary = platelets & lymphocytes
--- Cellular receptors:
1. Paaern RecogniLon Receptors (PRRs):
--- Recognises molecular paaerns (PAMPs) on infec2ous agents
--- Recognises products of cellular damage (DAMPs) — necrosis/apoptosis
--- PRRs are found on cells located at the interface of the host &
environment (skin, mucosa of respiratory tract, GI tract, GU tract)
· Toll---like receptors (TLRs)
· Complement receptors (CRs)
· Scavenger receptors (SRs)
· Glucan receptors, Mannose receptors
2. Toll---like Receptors (TLRs):
--- Homodimers or heterodimers — have a large geneLc polymorphism
· Highly preserved in phylogenesis (comes from plants)
--- TLRs are expressed on:
· APCs (macrophages, dendri2c cells)
· Mast cells
· Mucosal epithelial cells
· Some popula2ons of lymphocytes
· Neutrophils
--- Being located at the mucosal surface, they have direct & early contact
with potenLal microbes
--- PAMP recogni-on:
· LPS (bacterial lipopolysaccharide) — endotoxin
· Pep2doglycans
· Lipoproteins
· Viral coat proteins
· Bacterial flagellin
· Microbial nucleic acid
· Host factors produced by damaged cells (chroma2n, EC matrix)
--- During their recogni2on, they oUen collaborate with other receptors
(BCR/TCR), which will result in the release of cytokines
--- TLRs represent one of the bridges between innate resistance & adap2ve
immune response
1. Leukocyte rolling:
--- A normal, physiological & permanent phenomenon
--- The rolling is possible due to some adhesion molecules which produces a temporary
binding (not strong) between the leukocyte & endothelial cells
--- In this way, they produce a permanent, reversible surveillance of the endothelial cells
--- Molecules involved in this process are selecLns:
· L---selecLns = expressed on leukocyte surfaces
--- Works by binding to the GLYCAM 1 ligand
--- It is a transmembrane GP formed by an extracellular por2on (terminal lec2n
binding protein) which interacts with GLYCAM 1
· P---selecLns = expressed on platelet surfaces
· E---selecLns = expressed on endothelial cells (not always expressed)
--- They are expressed when endothelial cells start to become acLvated
--- They will interact with the N---acetyl---lactosaminoglycated protein ligand on
the leukocyte??
--- Binds to the E---selecLn ligands
· β1 integrins:
--- Types:
· VLA4 = on monocytes, lymphocytes, neutrophils
--- Interacts with:
· RGD ligand = contains L---arginine, glycine, aspar2c acid
· RGDS ligand = contains L---arginine, glycine, aspar2c acid + serine
· VitronecLn & fibronecLn in the EC matrix
4. Leukocytes acLvaLon:
--- Chemokines have 2 binding sites:
· 1 for leukocytes
· 1 for macromolecules on endothelial cells
--- Adhesion molecules coupled with chemokines will acLvate the leukocytes
· This leads to the ac2va2on of G---protein which ac2vates phospholipase C
· Phospolipase C will transform PIP2 —> IP3 + DAG
--- PIP2 = locally ac2vates the ac2n---myosin apparatus
· Leads to cell shape modifica2ons — pseudopod formaLon
· This will facilitate the migraLon of the leukocyte, allowing them to pass through
the endothelium by changing their shape
-- IP3:
· Release of Ca2+ from sER (contrac2lity)
· AcLvaLon of the acto---myosin apparatus (shape modifica2ons, cell mo2lity)
· DegranulaLon of lysosomes
-- DAG:
· AcLvates Protein kinase C —> phosphoryla2on
· AcLvates NADPH oxidase —> ini2ates the free oxygen radical cascade
· RegeneraLon & repair occurs in the last stages of acute inflammaLon (phagocytosis)
1. ReconstrucLve phase: filling of injured area with a clot
--- Mainly done by macrophages:
1. Transforming Growth Factor β (TGFβ) = chemotac2c factor for
fibroblasts to produce & secrete collagen
2. Growth Factors (VEGF, PDGF, FDGF) = akracts & s2mulates
endothelial cells to form new capillary beds growing into the lesion
3. Matrix metalloproteinases (MMPs) = degrada2on & remodelling of
EC matrix proteins
--- Debridement (scavengers) & clearing of the injured/infected area
--- Fibroplasia = fill in, seal & shrink the wound
· Angiogenesis — chemotaxis, mo2lity & ac2va2on
· Wound contracLon = fibroblasts can transform into myofibroblasts
which can contract, bringing the edges of the
wound together, shrinking it
· Remodelling
· GranulaLon & epithelialisaLon
2. MaturaLon phase
--- Scar remodelling
--- Mediated by MMPs
· Fibroplasia:
--- Depends on fibroblasts
--- MigraLon of the fibroblasts from the surrounding 2ssues via chemotaxis (specific or
non---specific (degrading products))
--- AcLvaLon & proliferaLon of fibroblasts
--- SecreLon of EC matrix proteins by the fibroblasts
DysfuncLons During The Inflammatory Response:
1. Hemorrhage: local factor
--- If there is a big hemorrhage at the site of injury & it is extensive, it is not beneficial
--- Increased number of erythrocytes = cleaning of the addi2onal erythrocytes by the
macrophages will require more 2me & effort
--- FormaLon of a big clot = larger space the granula2on 2ssue has to fill/replace
· This clot will also be a barrier for O2 diffusion at the site of injury (low
perfusion) which is not good
--- Increased amount of fibrin = needs to be fibrinolysed & later on absorbed
· Too much fibrin will favour fibrosis (increased granula2on 2ssue)
· The fibrin scar can impair the func2on of the organ
--- Increased accumulaLon of blood at the site of injury = if it stays there for a long
period of 2me it could be a poten2al culture medium for bacteria
1. Disturbances of Adhesion:
--- Leukocyte Adhesion Deficiency (LAD):
· It is a disease with autosomal recessive transmission
· The leukocytes can not adhere to the endothelial layer, thus can’t get ac2vated
· Leukocytosis s2ll occurs but leukocytes are not present at the site of injury
· No adhesion, transmigra2on or ac2va2on of leukocytes —> no repair processes
· Leads to ulceronecroLc lesions
--- LAD1 = defect in the gene responsible for β2 chain synthesis of the β2---integrins
· Neutrophils & macrophages aren’t ac-vated
--- LAD2 = structural defect of the Lewis oligosaccharide in the leukocyte’s membrane
· There is a deficiency in the fucosila0on and/or glucosila0on
· Adhesion using E---selec-ns is impaired
2. DysfuncLons in Chemotaxis:
--- Dysfunc-ons of the microfibrillar ac-n:
· Autosomal dominant transmission
· It evolves with LAD1 & LAD2
· The leukocytes aren’t responsive because G---acLn can’t transform into F---acLn
· Leukocytes adhere, but can’t form pseudopods
· It can also be seen in complicated diabetes mellitus
--- C3 deficiency:
· Can be acquired or hereditary (hepa2c failure)
· C3a deficiency = impaired vasodila2on & chemotaxis
· C3b deficiency = impaired opsonisa2on & phagocytosis
--- C5 deficiency:
· Inherited (autosomal dominant) or acquired (leukemias, nephro2c syndrome)
· C5a deficiency
· C5b deficiency = impaired MAC forma2on
3. Decreased PhagocyLc Capacity:
--- Opsonisa-on deficiencies:
· C3b deficiency = impaired opsonisa2ob & phagocytosis
· Chediak---Higashi disease:
--- An autosomal recessive disease
--- Dystrophy of the granules (altered shape) of neutrophils & macrophages
--- This causes lack of mediators (myeloperoxidase, lysozymes, cytochromes,
collegenase deficiency)
--- This will impair the microbicidal acLvity during phagocytosis